70+ Pharma Supply Chain Thought Leaders including:...

I especially appreciated the fact that most speakers come from the industry (and not solution

providers). We discussed actual problems and actual solutions –

exactly what I needed.

Sebastien Mauel, Head of Global

Product Security, Merck Serono

Logipharma 2012 was a very well organised event that provided a comprehensive overview of the latest knowledge on burning SCM topics. Key opinion leaders and senior executives were

present and available for best practice exchange. For SCM leaders, defi nitely a place to be.

Stephan Gotthardt, Corporate VP, Supply Chain

Management, Boehringer Ingelheim

The World’s Largest End-To-End Pharma Supply Chain Management Conference

Supply Chain Risk, Integrity & Security Summit – 23 April

Life Science Supply Chain Planning & Optimization Strategies – 24 & 25 April

Emerging Markets Supply Chain Strategy & Distribution Summit – 26 April

Hotel President Wilson, Geneva

www.logipharmaeurope.com

Supply Chain Risk, Integrity & Security Summit – 23 April

Achieving Supply Chain Process Excellence12th Annual

I especially appreciated the fact that most speakers come from I especially appreciated the fact that most speakers come from

Logipharma 2012 was a very well organised event that provided a comprehensive overview event that provided a comprehensive overview

problems and actual solutions – problems and actual solutions – exactly what I needed.

present and available for best practice exchange. present and available for best practice exchange. For SCM leaders, defi nitely a place to be.

70+ Pharma Supply Chain Thought Leaders including:

Alessandro De Luca

SVP, Head of Global Supply Network

Operations Merck Group

Carlo de NotaristefaniPresident and CEO of Global

Operations Teva

Tim ValkoExecutive Director,

Operations Risk Management

Amgen

Philippe LambotteSenior Vice

President - Supply Chain Management

Merck/MSD

Kristian SibilitzVice President,

Logistics Lundbeck

Lead Partner: Event Partners: Associate Partners:

Innovative servicesfor the Healthcare Market

Get the Latest Supply Chain Strategies

Pharma

Generics

Animal Health

from:

Register your place early to save up to £1,800

Plus many more

Key Supply Chain Issues Addressed:Ac

hieving Cost Control Forecasting

S&OPIm

proved

Risk

Manage

ment

Inventory Reduction

& New Markets

Globalisation

IntegritySecurity

Visibility

Su

pply

Chain

Exce

llence

ONE Unique Gathering

6 Key Take-Away Messages Per Session

70 Thought Leading Speakers

400 Life Science Supply Chain Leaders

Global Competition:As global competition increases, the need to formulate a market entrance strategy and grasp the full potential the emerging markets is crucial. Yet Pharma has still not come to grips with these markets in terms of both strategy and intent.

What are the pre-requisites of achieving the 50%+ growth predicted in frontier markets? How are leading organisations overcoming the challenges in manufacturing, distribution infrastructure and organisational design?

Key Session: Emerging Markets Supply Chain Strategy & Distribution Summit, April 26th: Effective cross-divisional supply chain organisation strategy in developing markets: Setting up the operating model to position supply chain as a lead growth driver.

Speaker: Philippe Lambotte, SVP Supply Chain, Merck

Product Security Concerns:

Are you prepared for the upcoming traceability and e-pedigree requirements and able to drive these benefi ts across the end to end supply chain beyond the regulatory obligations?

It’s diffi cult to continuously stay one step ahead of the criminals; it’s even harder when you are a step behind. Discover who is stealing your profi t, and ensure integrated approach to supply chain risk and integrity.

Key Session: Supply Chain Risk, Integrity & Security Summit: Tackling security and traceability from both a strategic and tactical level – Engaging with stakeholders and learnings from on-the-ground pilots.

Speaker: Jyrki Syvari, Corporate Director Supply Chain Integrity, Boehringer Ingelheim

Cost Pressures:We must be continually striving to optimise processes and retain as much margin as possible by optimising inventory, holding it in the right places and developing talent for tomorrow’s supply chain.

Distribution consumes as much as 2/3 of our costs to serve, yet this fundamental activity is often neglected. Hear new thinking on this key function in the context of globalisation and what you can do both before and after the rubber hits the road:

Key Session: Main Conference Day 1, 11:15: Distribution & Network design stream: Combating the margin decline – Global distribution cost avoidance strategies for mature markets.

Speaker: Stephan Gotthardt, Corporate Vice President Supply Chain Management, Boehringer Ingelheim

Increasing Regulatory Requirements:

Incoming regulatory requirements present us with hurdles every year.

Find out what the regulators expect from the industry and why. You’ll also be empowered with how to set our supply chains up to maintain compliance and quality.

Key Session: Main Conference Day 2, 14:40: Regulatory impacts on quality & temperature controlled distribution stream: The revised 2013 GDP directive A to Z

Speakers: Riekert Bruinink, Chief, Dutch Healthcare Inspectorate & member of the EMA GDP Draft Writing Committee

Yoram Eshel, Senior Director, Global Shipping and Logistics, Teva

Monika Derecque-Pois, Director General, GIRP

End-to-End Planning:Global volatility, market tender requirements, S&OP degradation and questions over quality – all themes that are placing stress upon the end-to-end planning organisation.

Ensure optimal planning structure, processes and tools that will support profi t maximisation during the Planning & Optimisation stream, April 25th.

Key Session: Main Conference Day 1, 11:15: Thinking ahead: The future of planning and S&OP.

Speakers: Andy Evans, Head of Global Supply Chain Planning, AstraZeneca & Michael Jarosch, Partner, Camelot Management Consultants

High Level SCM Strategy:Global supply chain heads attend LogiPharma every April to obtain the knowledge and inspiration to set their strategy road map for the coming years.

At a high level, the pharma industry is becoming a tougher environment to act within - the importance of the supply chain in the board room is rapidly accelerating.

Forging collaborations and building a broad network of thought leaders is critical to realising the full potential of your supply chain.

Key Session: Main Conference Day 1, 14.45: Invite Only VP Think Tank - A tailor-made discussion forum designed for and limited to supply chain VPs.

Moderator: Jolyon Austin, Managing Director, Life Sciences Supply Chain, Accenture

Join The Leading Experts In Life Science Logistics & Supply Chain

Key Supply Chain Issues Addressed:

Andy Evans, Head of Global Supply Chain Planning, AstraZeneca

Christoph Feldmann, Senior Director - Supply Chain Leader Alliance, Pfi zer Global Logistics & Supply

Hillel West, Executive Director, Operations and Supply Chain, Strategy, Teva Pharmaceuticals

James Hood, SVP Global Business Programme Owner, Mylan

John Koelink, Head of Global Supply Chain Management, Bayer HealthCare

Paolo Rosanna, VP Head of Business Development, Life Sciences & Healthcare EMEA, DHL Supply Chain

Philippe François,Vice President, Supply Chain EMEA, Baxter

Richard Holmes, Partner, Infosys Lodestone

Stephan Gotthardt, Corporate Vice President Supply Chain Management, Boehringer Ingelheim

Alessandro De Luca, SVP, Head of Global Supply Network Operations, Merck Group

Andreas Doerner, Senior Partner, Managing Director, CNT Management Consulting

Ann Merchant, President, Schreiner MediPharm

Aviad Bussi, Managing Director, SLE (Teva group)

Carl Segerstrom, Talent Management Leader - Emerging Markets, MSD

Carlo de Notaristefani, President and Chief Executive Offi cer of Global Operations, Teva Pharmaceutical Industries

Danny Hendrikse, Vice President EMEA Supply Chain Operations, Pfi zer

David Evans, Europe Supply Chain Business Director, GlaxoSmithKline

Denis Broun,Executive Director, UNITAID

Edgar Van Der Linden, Regional Commercial Director, Alloga Europe

Egbert Huensche, Head Global Supply Chain Development, Bayer Pharmaceuticals

Eric Leiglon, Director Demand & Supply Operations, Ferring Pharmaceuticals

Fabio Mioli, Director LSHC EMEA, DHL Supply Chain

Frank Binder, Senior Director International Logistics & Supply Chain, Celgene

Frédéric Bourgeois, AVP, Global Quality Supply Chain, Sanofi

Geert Robbrecht,Director LSHC EMEA, DHL Supply Chain

Helena Buckley, Director, Talent Management, Supply Chain, Johnson & Johnson

Helle Skov, Vice President, Global Supply Chain, Takeda

Henri Seroux, Senior Director, Manhattan Associates

Iain Richardson, Senior Director of Global Supply Chain, Eli Lilly

Jacques le Ny, Partner, Infosys-Lodestone

Dr Jean Francois Fusco, President, EALTH

Jim Barrington, Program Director “SMS for Life”, Novartis

John Sewell, Managing Consultant, Crimson & Co

Jolyon Austin, Managing Director, Life Sciences Supply Chain, Accenture

Julia Smirnova, Head of Business Development, Astra Logistic

Julian Amey, Principal Fellow, Warwick University

Jyrki Syvari, Corporate Director Supply Chain Integrity, Boehringer Ingelheim

Kerry Pickstone, Managing Consultant, Crimson & Co

Kirk Munroe, Vice President, Marketing, Kinaxis

Kristian Sibilitz, Vice President, Logistics, H. Lundbeck

Leif Kronkvist, Business Development Vice President, Agility

Manel Luis, Director Business Solutions EMEA, Pfi zer

Markus Ernst, Head of IS BP Global Business Services, Boehringer Ingelheim

Martin Eckert, Managing Director, Miebach

Michael Jarosch, Partner, Camelot Management Consultants

Mohammed Esa, Chief Executive Offi cer Dubai, Agility

Monika Derecque-Pois, Director General, GIRP

Oliver Glemser, Director Global Supply Chain Development, Ferring Pharmaceuticals

Oliver Scheel, Partner, Global Pharmaceutical Practice, A.T. Kearney

Pablo Moliner, Partner, Global Pharmaceutical Practice, A.T. Kearney

Peer Laslo, Principal Consultant, SAP Deutschland

Peter Smith, Director Planning & Deployment- EMEA, Baxter Healthcare

Philippe Lambotte, SVP Supply Chain, Merck & Co. a

Piero Sciotto, Senior Director, Head of Product Supply, Daiichi-Sankyo Europe

Prashant Yadav, Senior Research Fellow, University of Michigan

Ralf Schneider, Business Unit Manager, Essers Pharma Logistics

Riekert Bruinink, Chief, Dutch Healthcare Inspectorate

Robert Sebbag, Vice President Access to Medicines, Sanofi

Ronald Van Zitteren, Senior Director, Head of Global Distribution & Logistics, UCB Pharma

Shabbir Dahod, President and CEO, TraceLink

ConsultingMovilitas

Stefan Hockenberger, Sales & Marketing Manager, Movilitas Consulting

Thomas Ebel, Principal, McKinsey & Company

Thomas Goutay, Country Operations Director France Benelux, Baxter Healthcare

Tim Gittins, Regional IT Director, Alloga Europe

Tim Valko, Executive Director, Operations Risk Management, Amgen

Torben Vogt, Life Science Industry Expert, NNIT

Ulf Neuhaus, Global Supply Chain Management, Bayer HealthCare

Val Petursson, Director Logistics, Actavis

Wouter Asaert, Managing Consultant, Infosys-Lodestone

Yoram Eshel, Senior Director, Global Shipping and Logistics, Teva

Our Leading Advisory Committee:

Hear, Learn and Network with 70+ Pharma Supply Chain Experts:

Find out who attends LogiPharma. Request the attendee list todaywww.logipharmaeurope.com +44 (0) 20 7368 9465 [email protected]

3rd Annual Supply Chain Risk, Integrity & Security SummitTuesday 23rd April

WORKSHOP A:Product data change management, business

intelligence & master data done rightAnd how bad it can be when done wrong…

WORKSHOP B:Item serialization, compliance reporting and product

traceability with SAP Track & Trace solutions

WORKSHOP C:Recruiting, motivating & retaining talent

16:00 • The key to end-to-end visibility: communicating between supply and demand across multiple locations globally

• Master Data- The more we automate, the more important master

data settings become- It’s all about quality – how do you measure this?- Setting targets and KPIs- Exchanging master data with upstream suppliers to

optimise the supply chain- Navigating the complex regulatory issues- Transferring from launch site to manufacturing site

• Picture of master data gone wrong• Selling the need for consolidation and investment

internally – overcoming the unsexy factorEdgar Markwart, Distribution, Logistics and Master Data Vice President, Bayer HealthCareAdrian Barrass, Strategic Information Director, AstraZeneca

• Comply with country-specifi c legal regulations on serialization with one global solution

• Handle the creation, transfer and acknowledgement of notifi cations to authorities to achieve regulatory compliance

• Track business processes, assets, and goods in transit in real time

• Gain a corporate-level view on a cross-system product genealogy

• Execute precision product withdrawals and recallsPeer Laslo, Principal Consultant, SAP DeutschlandStefan Hockenberger, Sales & Marketing Manager, Movilitas Consulting

Developing a talent pipeline to meet the pharma’s current and future needs is one of the most pressing challenges facing SC management.

This workshop addresses several high level perspectives on how SC leaders are pushing human capital efforts internally within the SC, rather than leaving this key function to the traditional HR route.

• Crucial requirements to develop human capital• Building fl exibility and redundancy into organisational

structure by training people to be multi-skilled• SC management leader development – key capabilities• Developing the right solution for talent-resilient supply

chain organisation- Combating the high competition for talented

professionals in these regions- Overcoming the profession’s low profi le- Professional accreditation- Exploiting web-based training- On-going education, retention strategies and incentives

• Exporting talent to emerging regions without leaving a gap in established region capability

Carl Segerstrom, Talent Management Leader - Emerging Markets, MSDJulian Amey, Principal Fellow, Warwick UniversityHelena Buckley, Director, Talent Management, Supply Chain, Johnson & Johnson

17.30 Chairperson’s summary & end of summit

17.40 LogiPharma Europe networking drinks reception

19.30 LogiPharma Pre-Conference Networking Dinner

To be hosted by Camelot Management ConsultantsThis invitation-only dinner is solely for manufacturers attending Logipharma to network before the main conference begins. If you are interested in attending, please contact [email protected] Otherwise, you will receive a personal invitation from Camelot Management Consultants.

08:00 Registration and round-tables breakfast

08:45 Chairperson’s welcome and opening remarks Ann Merchant, President, Schreiner MediPharm (Former VP International Supply Chain, Amgen)

09.00 Opening keynote: Drivers for and industry response to need for pharmaceutical supply chain securityCriminal threats to the pharmaceutical supply chain are increasing and becoming more sophisticated: counterfeiting, theft, Internet sales, and smuggling/illegal diversion of medicines. Governments are responding to these threats with new requirements around supply chain security including serialization, good distribution practices and incident alerts. Companies are building comprehensive supply chain security programs to support patient safety. Rx-360 is one industry organization that provides a forum for companies to collaborate in sharing and benchmarking different aspects of these programs.

This key note talk will summarize these drivers including reviews of recent actual incidents and will introduce attendees the benchmarking whitepapers and networking Rx-360 is producing to assist the supply chain in enhancing security.

Tim Valko, Executive Director, Operations Risk Management, Amgen and Co-Chair, Rx-360 Supply Chain Security Initiative

09.30 Combining capacity and global risk management – diversifying centres of supply to manage and mitigate uncertainty worldwide• Balancing global supply and demand• Geopolitical risk considerations and the shift towards emerging markets as supply centres

- Increasing scrutiny of API materials by regulators – what this means for network footprints and GMP

- Supply surprises and realities on the ground• Fitting the strategy into an increasingly tender-based world• Ensuring preparedness for new markets and technologies

Hillel West, Executive Director, Operations and Supply Chain Strategy, Teva Pharmaceuticals

10.00 Tackling security and traceability from both a strategic and tactical level – Engaging with stakeholders and learnings from on-the-ground pilots• Global serialisation updates and pilots underway• Aggregation – the hidden challenge

- Manufacturing process challenges- Downstream distributor setbacks

• 1D vs. 2D barcode implementations• The role of worldwide harmonisation and patient safety

Jyrki Syväri, Corporate Director Supply Chain Integrity, Boehringer Ingelheim GmbH

10.40 Morning refreshments and networking SPEAKER’S CORNER

During the break, visit an area of the event dedicated to interaction with the previous session’s speakers and panellists. This is your opportunity to network and speak openly and candidly about any questions not covered during their session.

11.10 Case study: Securing the Sanofi supply chain• Where it all goes wrong – security & integrity done right, and how bad things can be

when done wrong

• Partnerships with regulatory bodies, customs and law enforcement – making the best use of your allies

• Active surveillance measures to take• The utility of dedicated laboratory resources and infrastructure• A layered approach towards product protection and security

Frédéric Bourgeois, AVP, Global Quality Supply Chain, Sanofi

11.45 Empowering an end-to-end serialization solution• Think beyond compliance – understand the full scope, direct and indirect of

Pharmaceutical Serialisation and reap signifi cant benefi ts for your company• Identifying the weakest link in your serialisation efforts, by thorough end-to-end

planning of your initiative• Choose an existing experienced full service provider with deep pharma and

serialization insight Torben Vogt, Life Science Industry Expert, NNIT

12.15 Networking luncheon SPEAKER’S CORNER

13.15 Security and serialisation think-tank: Driving the benefi ts throughout the supply chain• Quantifying the benefi ts beyond regulatory compliance and counterfeiting – valuable

applications in manufacturing, end to end visibility and optimisation and elsewhere• With European traceability regulations still in the distant future, and with supply chain

benefi ts readily evident, is now the right time to implement your own solution?• Putting systems in place now to enable serialization data to be used for a competitive

advantage• How do we overcome the implementation hurdles?

Senior Representative, Systech International

14.00 Case study: Global product traceability in pharmaceutical production with SAP Track & Trace solutions

Peer Laslo, Principal Consultant, SAP Deutschland Stefan Hockenberger, Sales & Marketing Manager, Movilitas Consulting

14.30 Californian E-Pedigree requirements - taking a leadership role to drive national standards with international impacts• History of the e-Pedigree movement• Determining the stakes at risk by delaying• Which technology solutions will maintain compliance – message/cloud/etc• Rule exemptions• Timelines: What must be done and by when?• Benefi ts to the recall process, patient health and manufacturer costs• Potential pre-emption by federal legislation / FDA action – what you need to know

about the introduction of a national drug supply chain security bill into Congress Awaiting confi rmation: Virginia Herold, Executive Offi cer, California State Board of

Pharmacy

15.00 TraceLink Session Shabbir Dahod, President and CEO, TraceLink

15.30 Afternoon coffee & networking SPEAKER’S CORNER

3rd Annual Supply Chain Risk, Integrity & Security SummitTuesday 23rd April

Main Conference Day One: Planning, Optimization & Distribution Strategies Wednesday 24th April 2013

08.00 Registration and refreshments

08.40 Conference director welcome and strategic outlook Tarley Cameron, LogiPharma Director, Worldwide Business Research

08.50 Chairperson’s opening remarks Jacques le Ny, Partner, Infosys-Lodestone

09.00 Keynote opening address: Designing a world-class supply chain: Balancing risks and opportunities

Carlo de Notaristefani, President and Chief Executive Offi cer of Global Operations, Teva Pharmaceutical Industries

09.30 Case Study: Enhancing collaboration and integration across the total supply network: Where innovation from outside industries can advance the Pharma industry effectiveness

Alessandro De Luca, SVP, Head of Global Supply Network Operations, Merck Group Paolo Rosanna, VP Head of Business Development, Life Sciences & Healthcare EMEA, DHL

10.00 Pharma Supply chain 2030 - shaping business opportunities Thomas Ebel, Principal, McKinsey & Company


18:15 Chairperson’s closing remarks, followed by drinks reception

19.00 - 21.00 Evening networking activity – Hosted by Lodestone

STREAM A:Planning & optimisation

STREAM B:Distribution & network design

STREAM C:Supply chain leadership & strategy forum

Chatham House Rules, PowerPoint-free11:15 Thinking ahead: The future of planning and S&OP

Today’s S&OP set up will often not support and provide the new required decision making capabilitiesAndy Evans, Head of Global Supply Chain Planning, AstraZenecaMichael Jarosch, Partner, Camelot Management Consultants

Panel debate: Dubai as a regional pharmaceutical hub: leveraging opportunities and growth across the Middle EastModerator: Mohammed Esa, Chief Executive Offi cer Dubai, AgilityLeif Kronkvist, Business Development Vice President, AgilityManel Luis, Director Business Solutions EMEA, Pfi zerPhilippe Francois, VP, Supply Chain EMEA, Baxter HealthcareVal Petursson, Director Logistics, Actavis

Case study: Optimising channel connectivity and leveraging key partners in the value chain: Cutting your lead time in halfUlf Neuhaus, Global Supply Chain Management, Bayer HealthCare

11:45 Dual perspectives: S&OP: Cutting through the marketing hype to make this workKerry Pickstone, Managing Consultant, Crimson & CoPeter Smith, Director Planning & Deployment- EMEA, Baxter Healthcare

Combating the margin decline: Global distribution cost avoidance strategies for mature marketsStephan Gotthardt, Corporate Vice President Supply Chain Management, Boehringer Ingelheim

Keynote: Postponement: Everybody’s still dreamingThe benefi ts to Life Science companies of postponement have the potential to be greater than for any other sector making it a worthwhile regulatory change endeavour, but only if you embrace what postponement truly means.

12:15 Case study: Collapsing planning cycles to drive better business outcomesKirk Munroe, Vice President, Marketing, Kinaxis

Supply Chains in the Pharmaceutical Industry: a Management topicMartin Eckert, Managing Director, Miebach

Panel debate: Redefi ning the service offering by enhancing segmentation and channel managementPhilippe Francois, VP, Supply Chain EMEA, Baxter HealthcareThomas Goutay, Country Operations Director France Benelux, Baxter HealthcareAlessandro De Luca, SVP, Head, Global Supply Network Ops, Merck Group

12:45 Networking luncheon SPEAKER’S CORNER

14:00 Case study: Pharma: One effi ciency, more than one Supply ChainHenri Seroux, Senior Director, Manhattan Associates

Panel debate: Distribution consolidation: Everyone’s doing it, but does it bring real value and optimisation?Frank Binder, Senior Director International Logistics & Supply Chain, CelgeneKristian Sibilitz, Vice President, Logistics, H. LundbeckRonald Van Zitteren, Senior Director, Head of Global Distribution & Logistics, UCB Pharma

Workshop: A practical route to segmentation within the supply chainKerry Pickstone, Managing Consultant, Crimson & CoJohn Sewell, Managing Consultant, Crimson & Co

14:45 Dual perspectives: Planning strategies to plan for and mitigate the effects of tenders Andy Evans, Head of Global Supply Chain Planning, AstraZeneca Eric Leiglon, Director Demand & Supply Operations, Ferring Pharmaceuticals

Cooperation to ensure optimal pharma distributionRalf Schneider, Business Unit Manager, Essers Pharma Logistics

Pharma VP Think TankA tailor-made discussion forum designed for and limited to supply chain VPsModerator: Jolyon Austin, Managing Director, Life Sciences Supply Chain, AccentureSee full details on the website: www.wbresearch.com/logipharmaeurope/thinktank.aspx

15:10 EALTH: A responsiveness organization in the EUDr Jean Francois Fusco, President, EALTH

15:30 Afternoon coffee SPEAKER’S CORNER

16:00 Balancing on-site and offshore services for supply chain management systems including a customer case studyAndreas Doerner, Senior Partner, Managing Director, CNT Management ConsultingMarkus Ernst, Head of IS BP Global Business Services, Boehringer Ingelheim

16:30 LogiPharma Industry Pulse interactive voting session: Up to the minute analysis of the latest supply chain impactsMichael Jarosch, Partner, Camelot Management Consultants

17:15

Join us in the Glowing Room for an evening of indulgence hosted by Lodestone. Sample 5 ‘Grand Cru’ Chocolates with their perfect wine pairing under the guidance of the resident 5* Pastry Chef. Alongside this, we have a local sommelier onsite keen to impress you with his selection of regional wines.

STRATEGY FOCUSED ROUND-TABLES & DRINKS RECEPTIONYour opportunity to join the debate and contribute in an intimate, relaxed environment

1. Innovative methods to deal with increasing supply chain requirements alongside higher volatility and uncertainties

Christoph Feldmann, Senior Director - Supply Chain Leader Alliance, Pfi zer Global Logistics & Supply

5. Optimising S&OP by better demand methodologies and planning David Evans, Europe Supply Chain Business Director, GlaxoSmithKline

2. Addressing change management in the life science and healthcare supply chain

Fabio Mioli, Director LSHC EMEA, DHL Supply Chain Geert Robbrecht, Director LSHC EMEA, DHL Supply Chain

6. What role can the supply chain play in planning for a product’s patent expiry – S&OP and mitigating the risk of scrap

3. Managing complexity within the non-patented product portfolio 7. Integrating global supply chains – goals and challenges Jacques le Ny, Partner, Infosys-Lodestone

4. Why Master Data is sexy and strategic Michael Jarosch, Partner, Camelot Management Consultants

5. Optimising S&OP by better demand methodologies and planning

BOOKED OUT 2011-2012 – BACK BY POPULAR DEMAND

Main Conference Day Two: New Product Launches & RegulationThursday 25th April

STREAM A:Regulatory impacts on quality &

temperature controlled distribution

STREAM B:New product launches & introductions

16.10 Case study: The challenge of the “CRT” out in the ambient temperatureYoram Eshel, Senior Director, Global Shipping and Logistics, Teva

Case study: Cross-functional teamwork to improve the product launch and product change processesOliver Glemser, Director Global Supply Chain Development, Ferring Pharmaceuticals

14.30 The revised 2013 GDP guidelines A to ZRiekert Bruinink, Chief, Dutch Healthcare Inspectorate & member of the EMA GDP Draft Writing CommitteeYoram Eshel, Senior Director, Global Shipping and Logistics, TevaMonika Derecque-Pois, Director General, GIRP

New Product Launch Round Tables

15.20 Afternoon coffee and networking SPEAKER’S CORNER

15.50 Regulatory Think TankParticipation from:• Regulator policy makers• Supply chain executives• Logistics providers

LogiPharma Café SessionThe perfect opportunity to meet with the experts to share experiences, problem solve challenges and strategize. Tables will be fl uid and open to all – with facilitators sharing the results to the entire audience at the end

16.40 Chairperson’s closing remarks SPEAKER’S CORNER

STREAM A:Emerging market end-to-end strategy

STREAM B:Pharmerging region distribution case studies

13.30 MDR-TB Case studyIain Richardson, Senior Director of Global Supply Chain, Eli Lilly

Security and integrity in Logistics and Distribution of the supply chain in Central AsiaJulia Smirnova, Head of Business Development, Astra LogisticSenior Representative, MCM Klosterfrau

14.00 Making an impact on patient health in Sub Saharan Africa through supply chain initiatives – the SMS For Life iniative• Tackling stock-outs and supply chain inadequacies with technology• Defi ning the process and designing the solution• Pilot results and impacts on the supply chain• Implications for the effi cient management of stock in frontier regionsJim Barrington, Program Director “SMS for Life” and former Corporate CIO, Novartis

India – Breaking through barriers with effective logistics strategies• Emerging markets defi ned: The Indian Healthcare Market Place • Practical considerations for Emerging Markets Logistics • Evaluating critical logistics challenges in a complex distribution market • Key logistics strategies to enable a forward looking supply chain in an evolving market

placeAwaiting confi rmation: Chetan Kumria, Director, Head of Supply Chain, Baxter India

Live Technology Demonstrations, Advice And Recommen dations From The Leading Solution Providers In the Field:

Pharma, Biotech, Generics, Animal Health: Attend LogiPharma with your Supply Chain Team for as little as £999 each for two full days of training!

08.00 Registration and LogiPharma Breakfast Round-tables

08.40 Chairperson’s welcome and opening remarks

09.00 Keynote opening address: The push into the emerging markets – what this means for the supply chain• Lack of growth in developed markets – what are the next steps for life science

companies?• The shift in focus to the bottom line, given lacking top line profi ts• Maintaining quality under pressure• Getting smarter on distribution strategy and channels• Assessing changing customer behaviours and the shift in demographics• Mastering complexity and knowing the trust cost to serve

Helle Skov, Vice President, Global Supply Chain, Takeda

09.40 Strategy: Visibility – The foundation for E2E supply chain performance and resilience• Increasing complexity of the pharma supply chain and the evolving regulatory

landscape• Balancing performance, complexity and risk across functional and corporate

boundaries – a core supply chain competence, built on accurate and sustainable visibility of the chain

• Achieving performance and resilience –exploiting E2E supply chain visibility and collaborative processes to radically improve your decision making and execution capabilities

Wouter Asaert, Managing Consultant, Infosys-Lodestone


10.50 Breakthrough technology that drives operational and competitive advantage for healthcare companies• Technology solutions that drive tangible value for healthcare companies• Enabling better and faster implementation• Greater information and insight into operational performance

Edgar Van Der Linden, Regional Commercial Director, Alloga Europe Tim Gittins, Regional IT Director, Alloga Europe

11.20 Outside industry innovation: A smarter supply chain by learning from the Automotive industry – Viable opportunities or wishful thinking?Linking theory and personal experiences of a former automotive professional• Pharmaceuticals vs. Automotive: Comparison of the status quo

• Challenges & Cultural change• Key fi ndings related to Supply Chain strategy and operations

- Globalization: Opportunities and Threats- Cost containment in times of change- Risk management: Area of confl ict or opportunity? - Supply chain visibility: Reporting and Performance Management- Communication & Integration: From the connection with suppliers to the

connection with customers Piero Sciotto, Senior Director, Head of Product Supply, Daiichi-Sankyo Europe

12.00 Outside industry innovation: Pharma versus FMCG: What can Pharma supply chain performance can learn from end-to-end complexity management in Fast Moving Consumer Goods?• Overview of benchmarks comparing Pharma vs. FMCG operations and supply chain

performance • Importance of end-to-end data transparency of the full value chain as a pre-requisite to

improve the supply chain and distribution networks• Why a different mind-set is required. Data analysis and smart concepts are not

enough. Transforming organizational culture of the organization and coaching leaders during the transition

• What specifi cally can Pharma learn from FMCG to improve current performance at reduced costs?

Oliver Scheel, Partner, Global Pharmaceutical Practice, A.T. Kearney


13.30 Case study: Going beyond Europe – Distribution strategies into Israel and emergent European markets• Market introduction – Israel unique pharmaceutical distribution market structure &

specifi cs • Evolution in our logistics during the last decade from a view of logistic centers’

projects:- Innovation in processes & automation- Cutting-edge QA standard & compliance- Unique services & customers

• What does the future have in store for pharma distribution?• Logistics platform as a leverage for adding value to customers and creating integrated

distribution chain advantages • Making a difference to the patient’s life, focus on the patient – future trends

Aviad Bussi, Managing Director, SLE (Teva group)

Emerging Markets Supply Chain Strategy & Distribution SummitFriday 26th April 2013

Main Conference Day Two: New Product Launches & RegulationThursday 25th April

08:00 Registration and coffee

08:45 Chairperson’s welcome and opening remarks Christoph Feldmann, Senior Director - Supply Chain Leader Alliance, Pfi zer Global Logistics &

Supply

09.00 Emerging Markets Supply Chain Strategy - Opening keynote addressBreaking barriers: transforming markets for greater impact for the poor

Denis Broun, Executive Director, UNITAID

09.20 Strategy Case Study: Effective cross-divisional supply chain organisation strategy in developing markets: Setting up the operating model to position supply chain as a lead growth driver

Philippe Lambotte, SVP Supply Chain, Merck

10.00 Rediscovering the power of trade channel strategies in new markets: How customer centred channel strategies and service effi ciency can help drive revenues and improve the bottom line

Pablo Moliner, Partner, Global Pharmaceutical Practice, A.T. Kearney


11.00 Discussion panel: Network design & distribution into developing markets – taking a fresh look at both the strategic and tactical model

Danny Hendrikse, Vice President EMEA Supply Chain Operations, Pfi zer Philippe Lambotte, SVP Supply Chain, Merck Prashant Yadav, Senior Research Fellow, University of Michigan

11.30 Adapting drug prices to consumer purchasing power to improve both access to affordable medicines and drive bottom line growth driven by SCM

Prashant Yadav, Senior Research Fellow, University of Michigan

12.00 Access to Medicines: Communication topic or real innovation for a big pharma?

Robert Sebbag, Vice President Access to Medicines, Sanofi


STREAM A:Emerging market end-to-end strategy

STREAM B:Pharmerging region distribution case studies

13.30 MDR-TB Case studyIain Richardson, Senior Director of Global Supply Chain, Eli Lilly

Security and integrity in Logistics and Distribution of the supply chain in Central AsiaJulia Smirnova, Head of Business Development, Astra LogisticSenior Representative, MCM Klosterfrau

14.00 Making an impact on patient health in Sub Saharan Africa through supply chain initiatives – the SMS For Life iniative• Tackling stock-outs and supply chain inadequacies with technology• Defi ning the process and designing the solution• Pilot results and impacts on the supply chain• Implications for the effi cient management of stock in frontier regionsJim Barrington, Program Director “SMS for Life” and former Corporate CIO, Novartis

India – Breaking through barriers with effective logistics strategies• Emerging markets defi ned: The Indian Healthcare Market Place • Practical considerations for Emerging Markets Logistics • Evaluating critical logistics challenges in a complex distribution market • Key logistics strategies to enable a forward looking supply chain in an evolving market

placeAwaiting confi rmation: Chetan Kumria, Director, Head of Supply Chain, Baxter India

The growing importance of the emerging markets will increase the challenges to Pharma companies. This dedicated day will bring together global supply chain leaders from both Europe and the emergent regions to discuss the core issues you are facing:

• Trends and market situation – pressures the pharmaceutical industry is facing in emerging markets

• The long range strategic opportunity – is it about an immediate commercial opportunity, or investment in the future?

• Public-private partnerships – improving health infrastructure and access to aff ordable medicines

• Adapting drug prices to consumer purchasing power to improve both access to aff ordable medicines and drive bottom line growth driven by SCM

• Breaking through barriers with eff ective logistics strategies and overcoming infrastructure limitations

• Ensuring supply chain quality, security & integrity in new markets

Live Technology Demonstrations, Advice And Recommen dations From The Leading Solution Providers In the Field:

Pharma, Biotech, Generics, Animal Health: Attend LogiPharma with your Supply Chain Team for as little as £999 each for two full days of training!

14.30 Afternoon coffee and networking SPEAKER’S CORNER

15.00

15.30 Chairperson’s closing remarks SPEAKER’S CORNER

Workshops & region-specifi c round-table case studies

1. Latin America 4. India

2. Russia 5. Sub-Saharan Africa

3. China 6. Asia Pacifi c

Job Function Breakdown

IndustryBreakdown

Worldwide Attendance From:

■ CxO ...................................10%

■ VP .....................................46%

■ Director............................26%

■ Manager ..........................18%

■ Pharma.............................64%

■ Biotech .............................18%

■ Generics .............................9%

■ Others ................................9%

AustriaBelgiumBulgariaCroatiaCanada

Czech RepublicDenmarkFinlandFrance

GermanyHong Kong

HungaryIrelandIsraelItaly

JapanKazakhstan

LatviaLithuania

PolandPortugal

Singapore

Serbia

Spain

Sweden

Switzerland

The Netherlands

Turkay

United Arab

Emirates

United Kingdom

United States

Head of Global Supply Chain Planning • Head of Distribution • Head of Global Supply

• Chain Enabling Capabilities • Supply Chain Planning • Distribution Network Director • Supply Chain IS Strategy

and Portfolio Manager

Global Supply Chain VP • Global Supply Director • Global Shipping

& Distribution Manager • Associate VP Technical Support & Compliance • Supply

Chain Process Improvement Manager • Manager S&OP and Supply Chain Performance • Director Product & Technology Support • Logistics

Services Senior Manager • Supply Chain Manager

Corporate VP, Operations Process Management & ERP Template • Chief of

Supply Chain Management • Corporate VP of Supply Chain Management • Director

Process & Systems Excellence • Director of Supply Chain Integrity

• Supply Chain Manager • Logistics Manager

VP EMEA Supply Chain Operations • Head of Supply Chain Alliance • EMEA Head of Supply Chain • EMEA Regional Alliance

Lead • Director Business Solutions EMEA • EMEA EM Alliance Lead •

EMEA Supply Chain Manager • Manager Network Design &

Market Access EMEA

Head of International Logistics and Supply Chain • Director Transactional Management • Assiociate Director •

Manager QA Logistics

Head of Service and Operations • Global Shipping and Logistics Director • Logistics

and Supply Chain Director • Manager, Budget & Control Department • European Supply Chain Manager

Head of Global Supply Chain • Head of Business Process Design • Director

Therapeutic Area Supply Chain • Supply Chain Planning Manager

Head of Global Supply Chain, Animal Health • Head Supply Chain Management HOBU • Europe Head of Logistics • Head Channel

Management Region EU • Head of Global Costumer Service • Head of

Global Supply Chain, Vaccines

Supply Chain and Manufacturing VP • European Distribution Associate Director • Associate Logisticts and Distribution

Director • Demand and Supply Manager

Head Global Supply Chain Development • Head of Supply Chain Management • Supply Chain Management SVP • VP

• VP of Strategy & Projects

Executive Director, Logistics Operations, EMEA • Logistics and Procurement Director • Director of Distribution, EMEA • Supply

Chain Strategy Lead MBV • Channel Logistics Manager • Global Logistics

Operations Lead - South & Mid Europe • Customer

Distribution Manager

Director Supply Chain EMEA • Sr. Director, Global Packaging Technology • Supply

Chain Product Strategy Director • Assoc. Director EU Distribution & Transportation • Distribution (EU

& ROW) Associate Director

Back by popular demand: Large Group Savings

www.logipharmaeurope.com+44 (0) 20 7368 9465

[email protected]

Pharma, Biotech, Generics, Animal Health:

Attend LogiPharma with your Supply Chain

Team for as little

as £999 each

for two full

days of

training!

Back by popular demand:

Attended By The Entire End-To-End Supply Chain Teams in 2012

64%

18%

9%

9%Individual

Registrations:

Confi rm your

place early

to save up to

£1,800 Contact us today:

Job Function Industry

Who You Will Be Meeting: Confi rm Your Place Today

70+ Pharma Supply Chain Thought Leaders including:...

Documents

Transcript of 70+ Pharma Supply Chain Thought Leaders including:...